For Exelixis’ excellent news, please read our latest article, "Exelixis’ (EXEL) Exceptional Financial Results and Corporate Achievements", under Today’s Highlights
Prohost Picked this firm on April 24, 2017, at $51 (see the Prohost Portfolio in the Prohost Letter). Today, Thursday, November 2, NBIX closed on at $72.78 Up $11.85
In its Q3 report, Neurocrine Biosciences (NBIX) announced financial results that beat analysts’ expectations by more than $30 million. The firm generated $60.77 million . . .